Concepedia

H. Lee

HL

Statistics

Publications

3

Citations

67

H-Index

3

Active since

2005

Affiliations

Bristol-Myers Squibb (United States)(Current)

H. Lee is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, chemotherapy, and medicine.

Publications per year

2005–2006

3

Publications

3

Ixabepilone (BMS-247550) plus trastuzumab combination chemotherapy induces synergistic antitumor efficacy in HER2 dependent breast cancers and is accompanied by modulation of molecular response markers

F. Y. Lee, Stephen Castaneda, Ivan Inigo et al. · Journal of Clinical Oncology · 2005 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Phase II genomics study in patients receiving ixabepilone as neoadjuvant treatment for breast cancer (BC): Preliminary efficacy and safety data

Antonio Llombart‐Cussac, José Baselga, G. Manikhas et al. · Journal of Clinical Oncology · 2005 · 18 citations

Medicine, Oncology, Pharmacology +17

Predictive biomarker discovery and validation for the targeted chemotherapeutic ixabepilone

H. Lee, L. Xu, Shujian Wu et al. · Journal of Clinical Oncology · 2006 · 17 citations

Medicine, Oncology, Pharmacology +11

1–3 of 3